<DOC>
	<DOCNO>NCT00544050</DOCNO>
	<brief_summary>The primary purpose study document pharmacokinetic parameter levetiracetam metabolite , ucb L057 , single dose 20 mg/kg levetiracetam epileptic pediatric subject , age 1 month less 4 year .</brief_summary>
	<brief_title>Pharmacokinetic Study Levetiracetam Epileptic Pediatric Subjects Ranging Age From 1 Month Less Than 4 Years Old</brief_title>
	<detailed_description />
	<mesh_term>Etiracetam</mesh_term>
	<mesh_term>Piracetam</mesh_term>
	<criteria>male female 1 month less 4 year diagnosis type epilepsy least 5 kg body weight use two antieplieptic drug treatable seizure etiology epilepsy secondary progressive cerebral disease progressively neurodegenerative disease history status epilepticus 2 week prior Selection Visit history presence pseudoseizures epilepsy surgery within one year prior Selection Visit ketogenic diet take felbamate Selection Visit</criteria>
	<gender>All</gender>
	<minimum_age>1 Month</minimum_age>
	<maximum_age>4 Years</maximum_age>
	<verification_date>September 2009</verification_date>
	<keyword>Levetiracetam</keyword>
	<keyword>Keppra</keyword>
</DOC>